首页> 外文期刊>Integrative cancer therapies. >The Effect of Peppermint (Mentha piperita) Extract on the Severity of Nausea, Vomiting and Anorexia in Patients with Breast Cancer Undergoing Chemotherapy: A Randomized Controlled Trial
【24h】

The Effect of Peppermint (Mentha piperita) Extract on the Severity of Nausea, Vomiting and Anorexia in Patients with Breast Cancer Undergoing Chemotherapy: A Randomized Controlled Trial

机译:薄荷(Mentha Piperita)提取物对乳腺癌化疗乳腺癌患者的恶心,呕吐和厌食的严重性:随机对照试验

获取原文
           

摘要

Background and Objective: Nausea, vomiting, and anorexia are the most common side effects reported in cancer patients undergoing chemotherapy. The present study aimed to determine the effect of peppermint extract on the severity of nausea, vomiting, and anorexia in patients with breast cancer undergoing chemotherapy. Methods and Materials: In this randomized controlled trial, we selected 84 patients with breast cancer undergoing chemotherapy. They were then assigned to 2 groups of experimental and control (n?=?42, each) using block randomization. Patients in the experimental group received 40 drops of peppermint extract mixed in 20?cc of tap water every 8?hours, while patients in the control group received 40 drops of distilled water mixed in 20?cc of tap water every 8?hours. The severity of nausea, vomiting, and anorexia was measured and recorded before the intervention, and immediately, 24 and 48?hours after the chemotherapy using the Visual Analogue Scale. Statistical analysis of the data was conducted using SPSS software version 21. Results: The results of the present study revealed that there was a significant difference between the 2 groups at 24 and 48?hours after the chemotherapy ( P??.05), so that the mean score of the severity of nausea, vomiting, and anorexia in the experimental group was lower than in the control group ( P??.05). Conclusion: The use of peppermint as a method in complementary medicine may improve nausea, vomiting, and anorexia in patients with breast cancer undergoing chemotherapy. Further studies with greater sample size and longer follow-up period are needed to confirm the current findings.
机译:背景和目的:恶心,呕吐和厌食是癌症患者进行化疗的最常见的副作用。本研究旨在确定薄荷提取物对乳腺癌患者进行化疗的恶心,呕吐和厌食的影响。方法和材料:在这种随机对照试验中,我们选择了84例乳腺癌患者进行化疗。然后,它们使用块随机化分配给2组实验和控制(n?=Δ22)。实验组中的患者每8?小时收到40滴薄荷的提取物混合在20℃下的自来水中,而对照组的患者接受了40滴蒸馏水,每8℃下加入自来水。在干预前测量并记录恶心,呕吐和厌食症的严重程度,并立即使用视觉模拟量表在化疗后的24和48小时。使用SPSS软件版本21进行数据的统计分析。结果:本研究结果表明,在化疗后24和48次,2组群之间存在显着差异(P?<〜05),因此,实验组中恶心,呕吐和厌食症严重程度的平均得分低于对照组(P?<β.05)。结论:薄荷作为互补药物中的方法的使用可能会改善乳腺癌接受化疗的患者的恶心,呕吐和厌食症。需要更大的样品大小和更长的随访时间进行进一步的研究来确认当前发现。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号